According to VEB Ventures, in the first quarter of 2020, global funding for healthcare companies increased by 72% compared to the same period last year and reached a record S3.6 billion. At the same time, telemedicine became the first health sector in terms of investment: total investments reached $ 788 million, and the market volume, according to Brand essence research 2019, last year the global telemedicine market reached an impressive $ 48 billion. Russian indicators are still far from global: according to VEB Ventures, at the end of 2019 the market of remote medical services was estimated at 1.5 billion rubles, but in the next five years the figure could rise a multiple - up to 96 billion with an average annual growth rate of 116%. The capitalization of a large foreign telemedicine company is comparable to the budget for healthcare in a small country: the market has huge potential, and its development is especially important for such a vast territory as the Russian Federation, where the distribution density of qualified medical care is uneven.
One of the drivers of the sharp increase in telemedicine, of course, was the COVID-19 pandemic: the load of clinics increased sharply, remote services attracted the attention of patients. For example, the joint project of the Doctor Near Clinic, VEB.RF and VEB Ventures provided 7,000 distance consultations in almost all regions of the Russian Federation for the first 20 days of operation, and many other companies launched similar services.
The trend is obvious: the digitalization of healthcare has reached Russia, which still lags significantly behind the long-established and prosperous world market. It's not just about telemedics - the Medtech industry is much wider than medical video consultations - the quality management system of clinic management, digital solutions in the field of diagnostics, medical Big Data analysis systems, and much more.
Today, the role of innovative projects in the medical field is greater than ever: investor attention is focused on perspective start-ups and already fledged projects that have successfully passed the sowing stage. A technological ecosystem is being formed, which is designed to provide the patient with quality service at each stage and optimize the costs of market players.

• What is holding back the development of MedTech in Russia?
• How to keep the demand of the Russian population for medical technologies increased due to a pandemic?
• What MedTech projects are Russian investors ready to invest in.
• Are Russian patients ready for distant treatment?
• How the industry will develop with the involvement of innovative projects.
• Can innovative technologies help optimize health care costs and improve the quality of care?
• The role of technology at all stages of patient care.